Champlain Investment Partners, LLC Dexcom Inc Transaction History

Champlain Investment Partners, LLC

$13.5 Billion
Q2 2025

A detailed history of Champlain Investment Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 1,791,100 shares of DXCM stock, worth $119 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

1,791,100

Previous 1,862,420 3.83%

Holding current value

$119 Million

Previous $127 Million 22.93%

% of portfolio

1.16%

Previous 0.98%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$59.83 - $87.57 $4.27 Million - $6.25 Million	-71,320 Reduced 3.83%	1,791,100 $156 Million
Q1 2025 May 14, 2025	SELL	$67.74 - $90.75 $10.4 Million - $13.9 Million	-153,293 Reduced 7.6%	1,862,420 $127 Million
Q4 2024 Feb 13, 2025	SELL	$65.68 - $81.01 $13 Million - $16 Million	-197,570 Reduced 8.93%	2,015,713 $157 Million
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $10.4 Million - $18.9 Million	163,210 Added 7.96%	2,213,283 $148 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $670,684 - $853,935	-6,080 Reduced 0.3%	2,050,073 $232 Million
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $6.15 Million - $7.54 Million	-53,830 Reduced 2.55%	2,056,153 $285 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $3.6 Million - $5.93 Million	-47,735 Reduced 2.21%	2,109,983 $262 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $22.7 Million - $36.4 Million	264,220 Added 13.95%	2,157,718 $201 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $687,191 - $800,287	6,110 Added 0.32%	1,893,498 $243 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $12 Million - $14.2 Million	115,429 Added 6.51%	1,887,388 $219 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $1.16 Million - $1.68 Million	-13,705 Reduced 0.77%	1,771,959 $201 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $21 Million - $25.9 Million	275,086 Added 18.21%	1,785,664 $144 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $92.9 Million - $182 Million	1,366,498 Added 948.43%	1,510,578 $113 Million
Q1 2022 May 12, 2022	BUY	$94.08 - $130.2 $13.6 Million - $18.8 Million	144,080 New	144,080 $73.7 Million

Others Institutions Holding DXCM

# of Institutions

1,108

Shares Held

368M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.

Account

Champlain Investment Partners, LLC Dexcom Inc Transaction History